SCHEDULE 13G
Statement of Beneficial Ownership
Perspective Therapeutics, Inc. Filed Acc 0000919574-26-001548
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| Avidity Partners Management LP | 6,049,999 | 5.3% |
| Avidity Partners Management (GP) LLC | 6,049,999 | 5.3% |
| Avidity Capital Partners Fund (GP) LP | 6,049,999 | 5.3% |
| Avidity Capital Partners (GP) LLC | 6,049,999 | 5.3% |
| Michael Gregory | 6,049,999 | 5.3% |
| Avidity Private Master Fund I LP | 5,849,999 | 5.1% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Stake history · largest stake in each 13D and 13G
- 2026-11-16 SCHEDULE 13G/A · Commodore Capital LP 5.5%
- 2026-11-12 SCHEDULE 13D/A · Lantheus Holdings, Inc. 3.9%
- 2026-11-10 SCHEDULE 13G · STATE STREET CORPORATION 1.8%
- 2026-09-23 SCHEDULE 13D/A · Lantheus Holdings, Inc. 7.7%
- 2026-09-04 SCHEDULE 13D/A · Lantheus Holdings, Inc. 10.0%
- 2026-08-13 SCHEDULE 13G/A · Millennium Management LLC 5.5%
- 2026-08-07 SCHEDULE 13G · STATE STREET CORPORATION 5.3%
- 2026-07-29 SCHEDULE 13G · BlackRock, Inc. 6.8%
- 2026-07-20 SCHEDULE 13G · Millennium Management LLC 5.3%
- 2026-06-30 SCHEDULE 13G · Millennium Management LLC 4.3%
- 2026-05-12 SCHEDULE 13G/A · Morgan Stanley 2.6%
- 2026-04-27 SCHEDULE 13G/A · BlackRock, Inc. 4.6%
- 2026-03-10 SCHEDULE 13G · Avidity Partners Management LP 5.3%
- 2026-02-12 SCHEDULE 13G · Morgan Stanley 6.0%
- 2026-02-09 SCHEDULE 13G · Commodore Capital LP 9.9%
- 2026-02-06 SCHEDULE 13G · Chen Yu 6.9%
- 2026-02-05 SCHEDULE 13G · Qatar Investment Authority 6.2%
- 2025-12-05 SCHEDULE 13G/A · FMR LLC 0.4%
- 2025-11-07 SCHEDULE 13G/A · FMR LLC 8.2%
- 2025-02-14 SCHEDULE 13G/A · JANUS HENDERSON GROUP PLC 0.0%
Loading xslSCHEDULE_13G_X01/primary_doc.xml…